Propafenone is a Vaughan Williams class 1c antiarrhythmic medication widely used for treatment of arrhythmias. Although the long-term safety of propafenone use has not been established, it is commonly used for treatment of atrial fibrillation in patients with no structural heart disease. Propafenone is well known as treatment for its effect in terminating paroxysmal episodes of atrial fibrillation. Herein, we discuss an unusual adverse reaction to propafenone in a patient who presented with symptomatic bradycardia and hypotension. The aim of this article is to increase physician awareness for propafenone toxicity and its management, with a focused literature review on propafenone pharmacotherapy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534703 | PMC |
| http://dx.doi.org/10.1136/bcr-2017-219270 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Safety Profile of Amiodarone Among Older Adults (age ≥ 75 years): A Pharmacovigilance Study from the FDA Data.
Am J Med
January 2025
The Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Sheba Medical Center, Ramat-Gan, Israel; Division of Geriatric Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. Electronic address:
Background: Amiodarone is a widely used antiarrhythmic agent with significant toxicities and drug interactions more likely to affect older adults. Nevertheless, data regarding amiodarone safety in this population are limited.
Methods: We conducted a retrospective analysis of FDA Adverse Event Reporting System (FAERS) data from 2003 to 2024 .
A case of propafenone toxicity in the setting of dehydration and acute kidney injury.
Glob Cardiol Sci Pract
August 2024
Department of Cardiology, Jefferson Abington Hospital, Abington, PA, USA.
Article Synopsis
- Propafenone is a class 1C antiarrhythmic medication commonly used to treat atrial fibrillation, but its toxicity, though rare, can be serious and lead to complications like hypotension and cardiac arrest.
- An 80-year-old male patient experienced symptoms caused by dehydration from excessive diuresis, resulting in serious changes on his ECG that were linked to propafenone toxicity.
- Managing the patient's fluid levels and temporarily stopping propafenone led to quick improvement in his heart rhythm, highlighting the need to consider factors like volume status when dealing with propafenone toxicity.
A Tissue Distribution Study of Propafenone in an Intentional Fatal Poisoning Case.
Int J Mol Sci
May 2024
Institute of Forensic Medicine, Faculty of Medicine, Comenius University Bratislava, Sasinková 4, 81108 Bratislava, Slovakia.
Propafenone (PPF) belongs to the class 1C antiarrhythmics and can cause electrocardiogram-associated adverse/toxic effects. Cases of PPF intoxication are rarely investigated. We developed a novel and selective GC-MS/MS method for the determination of PPF and its tissue distribution in an intentional fatal poisoning case, which is applicable to PPF quantification in the range of therapeutic to lethal concentrations in complex post-mortem samples.
View Article and Find Full Text PDFReassessing the Safety of Pill-in-the-Pocket Propafenone.
Cureus
September 2023
Cardiac Electrophysiology, Michigan State University, East Lansing, USA.
The current guidelines state that propafenone can be used in combination with a beta-blocker or a calcium channel blocker for pharmacologic cardioversion of recent-onset atrial fibrillation in patients without structural heart disease. To prevent the conversion from atrial fibrillation to atrial flutter with a rapid ventricular rate, it is recommended to administer propafenone following the administration of a beta-blocker or a calcium channel blocker. However, this combination carries the potential risk of cardiogenic shock.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!